Ethical microbiome research with Indigenous communities: A framework for collaboration and sovereignty

Despite a difficult investing environment, major well-capitalised contract manufacturing organisations (CMOs) have been involved in recent acquisitions, as big pharma and private equity alike highly value

A Cal­i­for­nia fed­er­al judge on Fri­day ap­proved a near­ly $247 mil­lion plan to set­tle claims that Gilead wrong­ful­ly kept gener­ic HIV com­peti­tors from the mar­ket.